SciSparc Ltd. (NASDAQ:SPRC) Short Interest Up 207.1% in April

SciSparc Ltd. (NASDAQ:SPRC) was the recipient of a significant growth in short interest in April. As of April 15th, there was short interest totalling 523,900 shares, a growth of 207.1% from the March 31st total of 170,600 shares. Approximately 21.4% of the company’s stock are sold short. Based on an average daily volume of 1,290,000 shares, the days-to-cover ratio is presently 0.4 days.

SciSparc Stock Up 4.8 %

Shares of SPRC opened at $1.32 on Friday. The stock has a 50 day moving average price of $2.42 and a 200 day moving average price of $4.18. SciSparc has a 52-week low of $1.15 and a 52-week high of $23.66.

About SciSparc

SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110 for the treatment of Tourette syndrome and Alzheimer's disease and agitation; SCI-160 for the treatment of pain; SCI-210 for the treatment of autism spectrum disorder and status epilepticus; and CannAmide, an anti-inflammatory and chronic pain solution.